RIZZI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 2.146
AS - Asia 1.707
EU - Europa 1.365
AF - Africa 156
SA - Sud America 74
OC - Oceania 2
Totale 5.450
Nazione #
US - Stati Uniti d'America 2.108
VN - Vietnam 512
SG - Singapore 454
CN - Cina 430
GB - Regno Unito 370
DE - Germania 183
IT - Italia 164
SE - Svezia 162
HK - Hong Kong 113
FR - Francia 102
RU - Federazione Russa 81
IN - India 79
NL - Olanda 69
IE - Irlanda 64
TG - Togo 64
BR - Brasile 51
FI - Finlandia 36
ZA - Sudafrica 36
EE - Estonia 30
BG - Bulgaria 21
CI - Costa d'Avorio 21
CA - Canada 20
UA - Ucraina 20
BE - Belgio 19
JO - Giordania 19
JP - Giappone 16
NG - Nigeria 15
MX - Messico 11
AR - Argentina 10
IR - Iran 10
TH - Thailandia 10
TW - Taiwan 10
BD - Bangladesh 9
TR - Turchia 9
CH - Svizzera 8
PH - Filippine 8
SC - Seychelles 8
ES - Italia 7
IQ - Iraq 7
LT - Lituania 7
PL - Polonia 6
PK - Pakistan 5
CL - Cile 4
HR - Croazia 4
KR - Corea 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
JM - Giamaica 3
KE - Kenya 3
AZ - Azerbaigian 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
ID - Indonesia 2
RO - Romania 2
UZ - Uzbekistan 2
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
CO - Colombia 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
IS - Islanda 1
LY - Libia 1
MF - Saint Martin 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
TN - Tunisia 1
UY - Uruguay 1
Totale 5.450
Città #
Southend 326
Singapore 303
Ashburn 259
Chandler 215
Fairfield 168
Hong Kong 109
San Jose 107
Santa Clara 98
Ho Chi Minh City 97
Wilmington 95
Houston 92
Seattle 90
Hanoi 89
Dong Ket 73
Ann Arbor 69
Princeton 65
Dublin 64
Lomé 64
Woodbridge 63
Beijing 54
Cambridge 53
Bologna 43
Boardman 42
Nanjing 39
Lauterbourg 34
Padova 32
Helsinki 31
Jinan 31
Westminster 31
New York 29
Berlin 24
Los Angeles 22
Abidjan 21
Bremen 21
Haiphong 21
Sofia 21
Shenyang 20
Turin 20
Tianjin 19
Amman 18
Brussels 18
Munich 18
Dallas 17
Dearborn 16
Hebei 16
Medford 16
Abeokuta 15
Da Nang 15
Buffalo 14
Falls Church 14
Frankfurt am Main 14
Saint Petersburg 14
Redondo Beach 13
San Diego 13
Guangzhou 12
São Paulo 12
Changsha 11
Florence 11
Mountain View 11
Tokyo 11
Toronto 11
Orem 10
Zhengzhou 10
Hangzhou 9
Hải Dương 9
Nanchang 9
Shanghai 9
Kuban 8
Milan 8
Düsseldorf 7
Haikou 7
London 7
Wuhan 7
Bexley 6
Brooklyn 6
Falkenstein 6
Stockholm 6
Bangkok 5
Basingstoke 5
Council Bluffs 5
Fuzhou 5
Istanbul 5
Ningbo 5
Norwalk 5
Phoenix 5
Redwood City 5
Turku 5
Amsterdam 4
Andover 4
Atlanta 4
Biên Hòa 4
Boston 4
Jiaxing 4
Kunming 4
Leawood 4
Modena 4
Monmouth Junction 4
Naples 4
Nuremberg 4
Olalla 4
Totale 3.590
Nome #
Adverse Features and Competing Risk Mortality in Patients With High-Risk Prostate Cancer 285
10 YEARS ONCOLOGIC OUTCOMES OF Robot-assISTED RADICAL PROSTATECTOMY: A PROPENSITY-SCORE MATCH ANALYSIS COMPARED WITH OPEN APPROACH 215
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 210
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 202
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. 199
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 196
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant: Results of an open, uncontrolled multicenter study 188
TRIFECTA RATES IN A COHORT OF PATIENTS UNDERGOING OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED PARTI AL NEPHRECTOMY FOR CLINICALLY LOCALIZED RENAL TUMORS AT LOW-INTERMEDIATE COMPLEXITY: A SINGLE-INSTITUTIONAL ANALYSIS 185
Nodal Occult Metastases in Intermediate- and High-Risk Prostate Cancer Patients Detected Using Serial Section, Immunohistochemistry, and Real-Time Reverse Transcriptase Polymerase Chain Reaction: Prospective Evaluation With Matched-Pair Analysis. 177
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF. 171
Impact of environmental enrichment on neurogenesis in the dentate gyrus during the early postnatal period. 169
Patterns of positive surgical margins after surgery in prostate cancer pa tients and their association with clinical recurrence 169
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 166
THE VALUE OF HISTOLOGICAL REVISION OF BIOPSY CORES IN PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: COMPARISON WITH SURGICAL SPECIMENS AFTER RADICAL PROSTATECTOMY AND CLINICAL FOLLOW-UP 165
Survival, continence and potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes 163
Survival, Continence and Potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes. 161
The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival Among Patients With Pathologic T3a Renal Cell Carcinoma 160
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 159
The value of histological revision of biopsy cores in patients suitable for active surveillance: comparison with surgical specimens after radical prostatectomy and clinical follow-up. 158
PERIOPERATIVE RESULTS , EARLY ONCOLOGICAL OUTCOMES AND TRIFECTA RATE IN PATIENTS UNDERGOING OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED PARTI AL NEPHRECTOMY FOR CLINICALLY LOCALIZED RENAL TUMORS: A SINGLE INSTITUTIONAL ANALYSIS 158
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 153
Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score. 147
THE PROGNOSTIC IMPACT OF TUMOR SIZE ON CANCER-SPECIFIC AND OVERALL SURVIVAL AMONG PATIENTS WITH PATHOLOGIC T3A RENAL CELL CARCINOMA 147
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas 147
VALIDATION OF PRIAS ACTIVE SURVEILLANCE CRITERIA IN PATIENTS SUBMITED TO RADICAL PROSTATECTOMY 146
[Predictors of positive surgical margins after nephron-sparing surgery for renal cell carcinoma: retrospective analysis on 298 consecutive patients]. 146
Revised Gleason Grading System Is a Better Predictor of Indolent Prostate Cancer at the Time of Diagnosis: Retrospective Clinical-Pathological Study on Matched Biopsy and Radical Prostatectomy Specimens. 146
PREOPERATIVE 11C-CHOLINE PET-CT IN INTERMEDIATE, HIGH RISK AND VERY HIGH RISK PROSTATE CANCER PATIENTS: IS THERE STILL ANY ROOM LEFT FOR IT? 139
Neonatal isolation impairs neurogenesis in the dentate gyrus of the guinea pig. 138
Warm ischemia time and postoperative complications after partial nephrectomy for renal cell carcinoma. 136
In patients with pathologically positive lymph nodes, three positive nodes represent a significant and independent cut-point for cancer-specific and overall survival 129
RUOLO DELLA LYMPH-NODE DENSITY NELL’OUTCOME ONCOLOGICO DEI PAZIENTI CON METASTASI LINFONODALI DA CARCINOMA prostatico SOTTOPOSTI A PROSTATECTOMIA RADICALE E LINFADENECTOMIA PELVICA 126
Validation of PRIAS Active Surveillance criteria in patients submitted to radical prostatectomy 97
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). 82
Totale 5.535
Categoria #
all - tutte 14.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.402


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022644 101 30 29 34 58 32 14 37 22 35 147 105
2022/2023826 74 172 50 105 56 58 24 53 146 16 59 13
2023/2024215 22 35 6 28 23 45 7 20 2 19 2 6
2024/2025742 31 82 53 70 120 44 39 29 5 90 17 162
2025/20261.650 145 105 125 101 197 95 168 32 430 175 40 37
2026/202719 19 0 0 0 0 0 0 0 0 0 0 0
Totale 5.535